Igor Fisch is the founder of NewBiologix. NewBiologix has raised $50M in total funding. Latest round: Series A. Backed by Recipharm A/S.
Igor Fisch is the Co-founder and CEO of NewBiologix, a company focused on advancing the production of advanced therapy medicinal products (ATMPs), particularly AAV vectors used in cell and gene therapies. He co-founded NewBiologix with Nicolas Mermod, raising USD 50 million in 2022 to establish the company and its technology platform.
Full founder directory · Investor directory · Company funding database · Fundraising library